Big Gain For Tempest Therapeutics, Inc.
Wed, Sep 16, 2026 at 07:32 PM
Tempest Therapeutics, Inc. (TPST:NASDAQ) rocketted at $1.21, representing a gain of 60.2%. On Wed, Sep 16, 2026, TPST:NASDAQ hit a New 2-Week High of $1.21. The stock got featured on our News Catalysts scanner on Wed, Sep 16, 2026 at 02:11 AM in the 'BIOTECH' category. From Wed, Sep 02, 2026, the stock recorded 22.22% Up Days and 30.00% Green Days
About Tempest Therapeutics, Inc. (TPST:NASDAQ)
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific...
Top 10 Gainers:
- Delixy Holdings Limited (DLXY:NASDAQ), 451.81%
- Q/C Technologies Inc Com Par $0.001 (QCLS:NASDAQ), 118.45%
- Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 78.68%
- Zenta Group Company Limited (ZTG:NASDAQ), 75.33%
- PDS Biotechnology Corporation (PDSB:NASDAQ), 69.25%
- Tempest Therapeutics, Inc. (TPST:NASDAQ), 60.18%
- Healthy Choice Wellness Corp. (HCWC:NYSEMKT), 40.52%
- 5E Advanced Materials, Inc. (FEAM:NASDAQ), 39.68%
- Jinxin Technology Holding Company (NAMI:NASDAQ), 36.84%
- Beneficient (BENF:NASDAQ), 36.06%